Zhang Chun-Lin

10PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 03, 2026
Coordinated circRNA Silencing and Chemotherapy by pH-Responsive Nanoparticles Reprogram Cell Death in Drug-Resistant Osteosarcoma.

|Mar 17, 2026
Efficacy of Ultrasonic Scalpel in Orthopaedic Oncology Surgery: An Initial Patient Cohort Study Based on Propensity Score Matching Analysis.

Jianping Hu, Jiazhuang Zhu, Zhen Huang

|May 19, 2025
Activation of HTR2B Suppresses Osteosarcoma Progression through the STAT1-NLRP3 Inflammasome Pathway and Promotes OASL1+ Macrophage Production to Enhance Antitumor Immunity.

Zhen Huang, Jiazhuang Zhu, Jianping Hu

|Jan 27, 2025
Advances in understanding the role of squalene epoxidase in cancer prognosis and resistance.

Jiazhuang Zhu, Yongjie Wang, Kunpeng Zhu

|Feb 19, 2024
Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index.

Yongjie Wang, Xiaolong Ma, Enjie Xu

|Oct 03, 2023
(E)-SIS3 suppressed osteosarcoma progression via promoting cell apoptosis, arresting cell cycle, and regulating the tumor immune microenvironment.

Zhen Huang, Chunlin Zhang, Kunpeng Zhu

Pageof 2

Frequent Collaborators

3 joint publications

Kunpeng Zhu

2 joint publications

Jianping Hu

2 joint publications

Yongjie Wang

1 joint publications

Yunlu Dai